Oncology & Cancer
FDA approves new drug for deadly lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
May 17, 2024
0
1
Lung Cancer
Oncology & Cancer
Breaking bad blood: How rogue neutrophils help lung cancer spread
Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide. Central to its development is the tumor microenvironment, which involves a complex interplay with ...
May 15, 2024
0
1
Oncology & Cancer
Report highlights big gaps in cancer outcomes based on race
U.S. cancer death rates are continuing to drop, falling by 33% between 1991 and 2020.
May 15, 2024
0
0
Oncology & Cancer
Cancer and COVID drove patient to double-lung transplant
Chicago resident Arthur "Art" Gillespie fell ill in early March 2020 with COVID, after he and his father went to visit an uncle in a nursing facility.
May 13, 2024
0
1
Oncology & Cancer
Projected estimates of cancer in Canada in 2024: Study
The number of cancer cases and deaths in Canada is expected to increase because of a growing and aging population, but the overall rates of people being diagnosed with and dying from cancer will continue to decline, according ...
May 13, 2024
0
0
Health
How science cleared the air over inhaled health risks
For a quick summary of the fight for clean air over the past century, look out of any office window.
May 13, 2024
0
0
Oncology & Cancer
A blood test to help detect lung cancer? New test offered at 18 locations
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she'd ever found time to do.
May 13, 2024
0
2
Oncology & Cancer
Cancer: Here's the role exercise plays, from prevention to treatment
Cancer is the second leading cause of death worldwide. In Europe, almost 3 in every 10 adults were diagnosed with a form of cancer in 2022.
May 9, 2024
0
29
Medications
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug ...
May 9, 2024
0
1
Medical research
Study identifies disparities in end-of-life care for lung cancer patients
Patients with lung cancer who were Asian/Pacific Islander, Black or Hispanic experienced a higher intensity of end-of-life care compared to white patients, according to a Northwestern Medicine population-based analysis published ...
May 8, 2024
0
1
